Search clinical trials for: BI 705564 (Reference)

Total 2054 results

Boehringer Ingelheim

Completed

Single Rising Dose Study of BI 690517 in Healthy Volunteers

Healthy

Germany
Boehringer Ingelheim

Completed

Efficacy and Safety of BI 2536 in Advanced or Metastatic Non Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Germany
Boehringer Ingelheim

Completed

A Study in Healthy Men to Test the Effects of Different Doses of BI 1467335 on MAO-B Activity in the Brain.

Healthy

United Kingdom
Boehringer Ingelheim

Terminated

Safety and Efficacy of BI 695500 in Patients With Moderately to Severely Active Rheumatoid Arthritis

Arthritis, Rheumatoid

United States, Belgium, Bulgaria, Germany, Greece, Netherlands, Poland, Portugal, Spain
Boehringer Ingelheim

Completed

Phase I Trial of BI 836845 for Various Solid Cancer

Neoplasms

Taiwan
Boehringer Ingelheim

Completed

Dose Escalation Study of BI 2536 BS in Patients With Advanced Solid Tumours With Repeated Administration in Patients With Clinical Benefit

Neoplasms
Boehringer Ingelheim

Terminated

Safety, Tolerability, Pharmacokinetics and -Dynamics of Multiple Rising Oral Doses of BI 113823 in Patients Patients With Osteoarthritis of the Knee

Osteoarthritis

Germany
Boehringer Ingelheim

Completed

HORNBILL: A Study to Test Different Doses of BI 764524 in Patients Who Have Had Laser Treatment for a Type of Diabetic Eye Disease Called Diabetic Retinopathy With Diabetic Macular Ischemia (HORNBILL)

Diabetic Retinopathy

United States, United Kingdom
Boehringer Ingelheim

Completed

Pharmacokinetics and Relative Bioavailability of 11634 Immediate Release Tablet in Healthy Male Volunteers

Healthy
Boehringer Ingelheim

Completed

Safety, Tolerability and Pharmacokinetics of BI 409306 Tablets in Healthy Asian Male Volunteers

Healthy

Korea, Republic of
Duke University

Completed

The Treatment Preferences of Women Diagnosed With Ovarian Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma

United States
AbbVie
Boehringer Ingelheim

Completed

Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe Psoriasis

Psoriasis

United States, Germany, United Kingdom
Boehringer Ingelheim

Completed

Safety, Antiviral Effect and PK of BI 207127 + BI 201335 +/- RBV for 4 up to 40 Weeks in Patients With Chronic HCV Genotype 1 Infection

Hepatitis C, Chronic

United States, Australia, Austria, France, Germany, New Zealand, Portugal, Romania, Spain, Switzerland
Boehringer Ingelheim

Completed

Safety, Tolerability and Pharmacokinetics of BI 653048 H3PO4 Oral Drinking Solution in Healthy Male Volunteers

Healthy
Boehringer Ingelheim

Completed

A Study in Healthy Men to Test How BI 1810631 is Taken up and Processed by the Body

Healthy

Netherlands
Baxter Healthcare Corporation

Not yet recruiting

ModPG3 Neo-Infant ISO 81060

Blood Pressure
Groupe Hospitalier Paris Saint Joseph

Recruiting

Comparison of Quality of Life With or Without Automatic Seton Placement in Perianal Crohn's Fistula (SOPA)

Crohn Disease

France
Second Affiliated Hospital of Wenzhou Medical University

Active, not recruiting

Drug Metabolism, Excretion, and Human Body Composition of Aximus Capsules

Bioequivalence Trial

China
Boryung Pharmaceutical Co., Ltd

Completed

A Clinical Trial to Compare the Pharmacokinetics and Safety of "BR1016A" With "BR1016B" in Healthy Volunteers

Chronic Heart Failure

Korea, Republic of
PepsiCo Global R&D

Completed

NBA G-League Sweat Testing Study: Validity of the Gx Sweat Patch in Measuring Sweating Rate and Sweat Chloride Concentration During On-court Training With Basketball Players

Sweat Analysis

United States
Chiesi Farmaceutici S.p.A.
Quintiles, Inc.

Completed

Pharmacokinetic Interaction and the Safety of Inhaled CHF5259 and CHF6001

Copd

United Kingdom
Boehringer Ingelheim

Completed

A Study in Healthy Men to Test How BI 1358894 is Taken up and Handled by the Body

Healthy

Netherlands
Dr Phillip J Buckhurst
BMI Southend Hospital

Completed

Clinical Investigation of the Bi Flex M Multifocal IOL

Cataract
Boehringer Ingelheim

Completed

Study in Healthy Male Subjects to Investigate Whether Ketoconazole Affects Plasma Exposure of BI 113823

Healthy

Germany
Boehringer Ingelheim

Completed

Multiple Rising Dose Study of BI 144807 Powder in Bottle in Mild Asthmatic Patients

Healthy | Asthma

United Kingdom
Boehringer Ingelheim

Completed

A Study in Healthy People to Test How 2 Different Formulations of BI 695501 Are Taken up by the Body When Given as an Injection

Healthy

United States
Boehringer Ingelheim

Completed

A Study to Test How Iclepertin is Taken up in the Blood of People With and Without Liver Problems

Hepatic Insufficiency

Germany
Boehringer Ingelheim

Completed

This Study in Healthy Men Tests How the Body Takes up BI 1467335

Healthy

Netherlands
Boehringer Ingelheim

Completed

Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 187004 CL

Healthy

Germany
Boehringer Ingelheim

Completed

Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 163538 XX

Healthy

Germany
Boehringer Ingelheim

Completed

Bioequivalence Trial of 2 Dose Strengths of BI 201335 NA Soft Gelatine Capsules

Hepatitis C

Japan
Boehringer Ingelheim

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 135585 XX in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

Germany
Boehringer Ingelheim

Completed

Single Rising Dose Study (Intravenous Infusion and Subcutaneous Injection) of BI 655064 in Healthy Male Volunteers

Healthy

Germany
Chong Kun Dang Pharmaceutical

Completed

Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388(2) in Healthy Subjects

Chronic Hepatitis b

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of DA-2803 in Healthy Subjects

Hepatitis B

Korea, Republic of
Astellas Pharma Global Development, Inc.

Completed

A Study to Assess Bioequivalence of Fezolinetant Formulations in Healthy Female Participants

Healthy Volunteers

United States
Meridian Bioscience, Inc.

Completed

Validation of the GenePOC Strep A, C/G Assay for Detecting Group A, C and G β-hemolytic Streptococcus From Throat Swabs.

Pharyngitis, Infective

United States, Canada
Meridian Bioscience, Inc.

Completed

Validation of the GenePOC GBS Assay for the Detection of the Cfb Gene From Streptococcus Agalactiae Strains

Streptococcus Agalactiae Infection

Canada, United States
Chong Kun Dang Pharmaceutical

Unknown

Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388 in Healthy Subjects

Chronic Hepatitis b

Korea, Republic of
GlaxoSmithKline

Completed

Evaluation of a Experimental Denture Adhesive to Prevent Food Ingress

Denture Retention

United States
University of Texas at Austin

Completed

Guided Imagery Training and Self-Referential Processing

Depression | Negative Thoughts

United States
Seoul National University Gwanak Dental Hospital

Completed

Repetition Improves Precision and Trueness of Digital Intraoral Scans

Tooth Diseases

Korea, Republic of
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

A Study of Inhalation of 20,000 EU CCRE in Normal Volunteers Compared to Allergic Asthmatic Individuals (Endomac)

Hypersensitivity | Asthma

United States
JW Pharmaceutical

Completed

To Evaluate the PK, PD, Safety and Drug Tolerance of JW0302 in Healthy Volunteers

Healthy

Korea, Republic of
Eli Lilly and Company

Completed

A Study of LY3337641 in Healthy Participants

Healthy

Singapore
Meridian Bioscience, Inc.

Completed

Validation of the GenePOC CDiff Assay for the Detection of the Toxin B Gene From Toxigenic Clostridium Difficile Strains

Clostridium Difficile Infection

United States, Canada
Chong Kun Dang Pharmaceutical

Completed

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-385 in Healthy Volunteers

Cardiovascular Diseases

Korea, Republic of
Kantonsspital Winterthur KSW
University of Zurich; Zurich University of Applied Sciences

Completed

Prehabilitation - Enhanced Recovery After Colorectal Surgery (pERACS)

Colorectal Surgery | Surgical Operation With Reversal of External Stoma

Switzerland
Eli Lilly and Company

Completed

Single Dose Study in Healthy Participants to Investigate the Safety and Absorption of LY2584702

Healthy Participants

Singapore
Assistance Publique - Hôpitaux de Paris
University Hospital, Clermont-Ferrand; Rennes University Hospital; Nantes University...

Unknown

Pulpotomy vs Pulpectomy Outcome. (PULPSAVE)

Inflammatory Pulp Diseases Related to Carious Teeth

France

3

Subscribe